Evidence map›Paper›PMID 41026257›Full record

ArticleJournal of clinical immunology2025

Homozygous Loss of Function PIK3CD Mutation in Multiple Siblings Leading To B Cell Dysregulation and Autoimmunity.

Huda Alajlan, Amer Al-Mazrou, Hibah Alruwaili, Safia Sumayli, Ali Almehaidib, Khalid Alsaleem, Sawsan Abu Awwad, Hazem Ghebeh, Monther Al-Alwan, Anas M Alazami and 1 more

Abstract readCase Reports
In one paragraph

Article in Journal of clinical immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Huda AlajlanDepartment of Translational Genomics, Genomic Medicine Centre of Excellence, King Faisal Specialist Hospital and Research Centre, Riyadh, MBC-03 PO BOX 3354, 11211, Saudi Arabia.
Amer Al-MazrouCell Therapy & Immunobiology Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Hibah AlruwailiDepartment of Translational Genomics, Genomic Medicine Centre of Excellence, King Faisal Specialist Hospital and Research Centre, Riyadh, MBC-03 PO BOX 3354, 11211, Saudi Arabia.
Safia SumayliDepartment of Medicine, Section of Allergy/Immunology, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
Ali AlmehaidibDepartment of Pediatrics, Section of Pediatric Gastroenterology, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
Khalid AlsaleemDepartment of Pediatrics, Section of Pediatric Gastroenterology, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
Sawsan Abu AwwadDepartment of Pediatrics Section of Allergy and Immunology, King Faisal Specialist Hospital and Research Center, Riyadh, MBC-58 P.O.Box 3354, 11211, Saudi Arabia.
Hazem GhebehCell Therapy & Immunobiology Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Monther Al-AlwanCell Therapy & Immunobiology Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Anas M AlazamiDepartment of Translational Genomics, Genomic Medicine Centre of Excellence, King Faisal Specialist Hospital and Research Centre, Riyadh, MBC-03 PO BOX 3354, 11211, Saudi Arabia. amalazami@kfshrc.edu.sa.
Hamoud Al-MousaCollege of Medicine, Alfaisal University, Riyadh, Saudi Arabia. hamoudalmousa@kfshrc.edu.sa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phosphatidylinositol 3-kinases (PI3Ks) are heterodimeric lipid kinases that are involved in a diverse array of cellular functions such as growth, metabolism, and migration. Mutations in PIK3CD, which encodes an immune-specific catalytic subunit of PI3K, cause both dominant (activating) and recessive (loss of function) immune deficiencies in humans. Here we report a family with three affected children carrying a novel bi-allelic, truncating mutation in PIK3CD. All three patients exhibited chronic diarrhea and recurrent sinopulmonary infections. Immunoblot confirmed loss of protein along with reduced expression of the associated p85α regulatory subunit. Immune phenotyping showed B cell dysregulation with abnormally high levels of naïve cells. In vitro functional testing of CD19 + and enriched naïve B cells revealed impaired proliferation, and reduction in class-switch recombination upon CD40L and IL-21 stimulation. Our data raise the possibility that PI3K-related dysregulation in human B cells may be broader than in mouse models, where class-switch recombination can still occur with external T cell help. Our study substantially increases the limited number of patients known to have immune deficiency due to loss of PIK3CD.

Indexed as

AutoimmunityB-LymphocytesClass I Phosphatidylinositol 3-KinasesLoss of Function MutationChildChild, PreschoolFemaleHomozygoteHumansMaleMutationPedigreeSiblingsClass I Phosphatidylinositol 3-KinasesPIK3CD protein, humanHypogammaglobulinemiaLoss of functionP110δP85PI3KδPrimary immunodeficiency

Identifiers

PMID41026257
PMCPMC12484089

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.